"Myocardial Reperfusion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing MYOCARDIAL REPERFUSION INJURY.
| Descriptor ID |
D015425
|
| MeSH Number(s) |
E04.100.700.600 E05.680.730.600
|
| Concept/Terms |
Myocardial Reperfusion- Myocardial Reperfusion
- Reperfusion, Myocardial
- Myocardial Reperfusions
- Reperfusions, Myocardial
- Coronary Reperfusion
- Coronary Reperfusions
- Reperfusion, Coronary
- Reperfusions, Coronary
|
Below are MeSH descriptors whose meaning is more general than "Myocardial Reperfusion".
Below are MeSH descriptors whose meaning is more specific than "Myocardial Reperfusion".
This graph shows the total number of publications written about "Myocardial Reperfusion" by people in this website by year, and whether "Myocardial Reperfusion" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 10 | 5 | 15 |
| 2018 | 1 | 3 | 4 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Myocardial Reperfusion" by people in Profiles.
-
Effect of age, gender, and time of day on pain-to-call times in patients with acute ST-segment elevation myocardial infarction: the CLOC’AGE study. Emergencias. 2021 06; 33(3):181-186.
-
Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry. Biomed Pharmacother. 2021 Jun; 138:111469.
-
Impact of Coronavirus Disease 2019 Pandemic on the Incidence and Management of Out-of-Hospital Cardiac Arrest in Patients Presenting With Acute Myocardial Infarction in England. J Am Heart Assoc. 2020 11 17; 9(22):e018379.
-
Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic. J Int Med Res. 2020 Oct; 48(10):300060520966151.
-
Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center. Am Heart J. 2020 08; 226:45-48.
-
The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic. Circulation. 2020 06 16; 141(24):1951-1953.
-
Impact of COVID-19 on reperfusion strategies for acute coronary syndromes. Arch Cardiol Mex. 2020; 90(Supl):62-66.
-
Decision to deploy coronary reperfusion is not affected by the volume of ST-segment elevation myocardial infarction patients managed by prehospital emergency medical teams. Eur J Emerg Med. 2019 Dec; 26(6):423-427.
-
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets. Hellenic J Cardiol. 2019 Nov - Dec; 60(6):397-399.
-
[Regional network for ST-elevation myocardial infarction in Italy: from development to management]. G Ital Cardiol (Rome). 2018 Dec; 19(12):721-723.